Realbio zero batch to batch difference bovine serum
Published Time:
2024-03-11
Author:
Source:
Abstract
Details make perfect. Only with quality can things be accomplished. Realbio considers many aspects and performs real-time index detection at each stage, continuously reducing batch-to-batch differences to ensure high-quality bovine serum. Our goal is to provide customers with the best products, free from the worries of batch-to-batch variations, allowing customers to conduct experiments and produce products with peace of mind.
Keywords:
IVD Raw Materials | Biological Products
HOT NEWS
On May 12, the strategic signing ceremony between Realbio and Thermo Fisher Scientific, a global leader in scientific services, was successfully held at the Thermo Fisher Customer Experience Center in Shanghai. The two parties will engage in in-depth collaboration on "integrated solutions for in-vitro diagnostic quality control materials," jointly embarking on a new chapter of resource sharing and value co-creation. Attendees at the signing ceremony included Patrick Jones, Global President of Professional Diagnostics at Thermo Fisher; Anuj Dhingra, Global Vice President of Professional Diagnostics; Linda Tang, Commercial Director of Professional Diagnostics, China; Luca Saronni, Global Chief Business Development Manager of Clinical Diagnostics; Liangchao Huang, Senior Sales Manager of Clinical Diagnostics, China; Anita Zhang, Product Specialist of Clinical Diagnostics Marketing, China; as well as Su Shaobo, Chairman of Shenzhen Realbio Group; Jiang Wenyu, Deputy General Manager of Operations; and Ji Hongyu, International Business Development Manager. This signing represents not only a joining of hands between the two enterprises but also another significant milestone for Ruiyali in enhancing its local industrial translation capabilities.
2026-05-12
On April 9, Realbio Group and the Shenzhen CDC officially signed a strategic cooperation agreement in Shenzhen. The two parties will engage in in-depth collaboration on the construction of a clinical translation evaluation system for in-vitro diagnostics (IVD), with the aim of bridging the "last mile" from the laboratory to clinical application, enhancing the industry's regulatory market access capabilities, and contributing to the development of a public service platform for the diagnostics field in the Greater Bay Area.
2026-04-10
Realbio Debuts at the 23rd CACLP: Integrated CRO Central Lab Model Accelerates IVD Registration
On March 21, 2026, the 23rd China Association of Clinical Laboratory Practice Expo (CACLP) — the annual bellwether of the IVD industry — grandly opened at the Xiamen International Expo Center. As an enterprise specializing in upstream core raw materials and integrated services for IVD, Realbio made a striking debut with its "CRO New Model for the Full Lifecycle of IVD Registration," demonstrating how, driven by global resource integration and local translation capabilities, it empowers partners to achieve compliant growth, cost reduction, and efficiency gains.
2026-03-23
Headquarters address: Building 1, Shenfubao Science and Technology Ecological Industrial Park, No. 18 Jinxiu West Road, Pingshan District, Shenzhen
Copyright © 2021 Shenzhen Realbiogroup Co.,Ltd | www.300.cn | Privacy policy
City Substation
Business License